Clinical Trial Update: Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma [Phase 3]

View source ↗

Summary

It reports an ongoing Phase 3 trial comparing shortened versus standard chemotherapy combined with immunotherapy as initial treatment for high-tumor-burden foll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Follicular Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING